Biofrontera (BFRI) Earnings Date, Estimates & Call Transcripts $0.57 -0.04 (-6.92%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Biofrontera Earnings Summary Biofrontera released Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.47, which missed analysts' consensus estimates of -$0.14 by $0.33. Quarterly revenue was reported to be $8.59 million, below analysts' expectations of $10.55 million. With a trailing EPS of -$2.26, Biofrontera's earnings are expected to grow next year, from ($3.01) to ($0.55) per share. Upcoming Q2 Earnings DateAug. 13After Market ClosesEstimatedConsensus EPS (May. 15) -$0.14 Actual EPS (May. 15) -$0.47 Missed By -$0.33 Actual Revenue (May. 15) $8.59MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)BFRI Upcoming EarningsBiofrontera's next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Biofrontera Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biofrontera and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBFRI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BFRI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Biofrontera Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.45-$0.45-$0.45Q3 20251-$0.31-$0.31-$0.31Q4 20251$0.00$0.00$0.00 Biofrontera Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/15/2025Q1 2025-$0.14-$0.47 -$0.33-$0.47$10.55M$8.59M8/14/2024Q2 2024-$1.19-$1.12+$0.07-$2.19$9.02M$7.84M5/15/2024Q1 2024-$1.63-$1.85 -$0.22-$0.82$11.52M$7.91M3/15/2024Q4 2023--$2.33 -$2.33-$6.31-$10.60M11/10/2023Q3 2023-$4.23-$4.64 -$0.41-$4.64$8.87M$8.90M8/11/2023Q2 2023-$5.14-$6.14 -$1.00-$5.05$5.86M$5.85M Biofrontera Earnings - Frequently Asked Questions When is Biofrontera's earnings date? Biofrontera has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on BFRI's earnings history. Did Biofrontera beat their earnings estimates last quarter? In the previous quarter, Biofrontera (NASDAQ:BFRI) missed the analysts' consensus estimate of ($0.14) by $0.33 with a reported earnings per share (EPS) of ($0.47). Learn more on analysts' earnings estimate vs. BFRI's actual earnings. How can I listen to Biofrontera's earnings conference call? The conference call for Biofrontera's latest earnings report can be listened to online. Listen to Conference Call How can I read Biofrontera's conference call transcript? The conference call transcript for Biofrontera's latest earnings report can be read online. Read Transcript How much revenue does Biofrontera generate each year? Biofrontera (NASDAQ:BFRI) has a recorded annual revenue of $38.00 million. How much profit does Biofrontera generate each year? Biofrontera (NASDAQ:BFRI) has a recorded net income of -$20.13 million. BFRI has generated -$2.26 earnings per share over the last four quarters. What is Biofrontera's EPS forecast for next year? Biofrontera's earnings are expected to grow from ($3.01) per share to ($0.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies Tenax Therapeutics Earnings Tempest Therapeutics Earnings NanoViricides Earnings Cara Therapeutics Earnings Cyclo Therapeutics Earnings Pulmatrix Earnings Enlivex Therapeutics Earnings Clene Earnings CASI Pharmaceuticals Earnings ABVC BioPharma Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the Stock This page (NASDAQ:BFRI) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
